Arbutus Biopharma Corp (ABUS)
3.18
-0.01
(-0.31%)
USD |
NASDAQ |
Dec 24, 16:00
Arbutus Biopharma Cash from Investing (Quarterly): -11.99M for Sept. 30, 2024
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Biomarin Pharmaceutical Inc | -16.16M |
| Amicus Therapeutics Inc | 34.27M |
| Ionis Pharmaceuticals Inc | -340.80M |
| GlycoMimetics Inc | 0.00 |
| FibroGen Inc | 0.755M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -20.74M |
| Cash from Financing (Quarterly) | 1.775M |
| Free Cash Flow | -71.92M |
| Free Cash Flow Per Share (Quarterly) | -0.1097 |
| Free Cash Flow to Equity (Quarterly) | -20.74M |
| Free Cash Flow Yield | -12.54% |